Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - India
Summary - Inj. Insulin Lispro 25% + Insulin Lispro Protamine Suspension 75% (R-Dna Origin) - 100 Iu/Ml, 3 Ml Cartridge (01 Pen + 2.
Deadline - Oct 28, 2025
GT reference number - 120168309
Product classification - General anti-infectives for systemic use and vaccines
Address - India
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 120168309
Document Type - Tender Notices
Description - notice_title: Inj. Insulin Lispro 25% + Insulin Lispro Protamine Suspension 75% (R-Dna Origin) - 100 Iu/Ml, 3 Ml Cartridge (01 Pen + 2.local title:: Inj. Insulin Lispro 25% + Insulin Lispro Protamine Suspension 75% (r-DNA origin) - 100 IU/ml, 3 ml Ca rtridge (01 Pen + 2.Contract Type: : Supply
Gt Ref Id - 120168309
Deadline - Oct 28, 2025
Similar Tenders :
Summary:
|
Summary:
|
Summary:
|
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database